Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence
- 7 December 2007
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 101 (3) , 325-329
Abstract
OBJECTIVE: To evaluate the urodynamic data before and 6 months after implantation of sacral neuromodulation (SNM, an established treatment for voiding dysfunction, including refractory urge urinary incontinence, UI) and to assess the correlation between the urodynamic data and clinical efficacy in patients with UI. PATIENTS AND METHODS: In all, 111 patients with a >50% reduction in UI symptoms during a percutaneous nerve evaluation test qualified for surgical implantation of SNM. Patients were categorized in two subgroups, i.e. those with UI with or without confirmed detrusor overactivity (DO) at baseline. At the 6‐month follow‐up all patients had a second urodynamic investigation, with the stimulator switched on. RESULTS: At baseline, there was urodynamically confirmed DO in 67 patients, while 44 showed no DO. A review of filling cystometry variables showed a statistically significant improvement in bladder volumes at first sensation of filling (FSF) and at maximum fill volume (MFV) before voiding for both UI subgroups, compared with baseline. In 51% of the patients with UI and DO at baseline, the DO resolved during the follow‐up. However, those patients were no more clinically successful than those who still had DO ( P = 0.73). At the 6‐month follow‐up, 55 of 84 implanted patients showed clinical benefit, having a ≥50% improvement in primary voiding diary variables. Patients with UI but no DO had a higher rate of clinical success (73%) than patients with UI and DO (61%), but the difference was not statistically significant. CONCLUSION: These urodynamic results show a statistically significant improvement in FSF and MFV in patients with UI with or with no DO after SNM. Although there was a urodynamic and clinical improvement in both groups, patients with UI but no DO are at least as successful as patients with UI and DO. Therefore in patients with UI, DO should not be a prerequisite selection criterion for using SNM.Keywords
This publication has 16 references indexed in Scilit:
- Sacral Neuromodulation in Women With Idiopathic Detrusor Overactivity Incontinence: Decreased Overactivity but Unchanged Bladder Contraction Strength and Urethral Resistance During VoidingJournal of Urology, 2006
- Efficacy of sacral neuromodulation for symptomatic treatment of refractory urinary urge incontinenceUrology, 2006
- Long Term Results of Neuromodulation by Sacral Nerve Stimulation for Lower Urinary Tract Symptoms: A Retrospective Single Center StudyEuropean Urology, 2006
- Canadian experience in sacral neuromodulationUrologic Clinics of North America, 2005
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- SACRAL NERVE STIMULATION FOR TREATMENT OF REFRACTORY URINARY URGE INCONTINENCEJournal of Urology, 1999
- SACRAL NERVE ROOT NEUROMODULATION: AN EFFECTIVE TREATMENT FOR REFRACTORY URGE INCONTINENCEJournal of Urology, 1998
- URGE INCONTINENCEUrologic Clinics of North America, 1996
- Sacral (S3) Segmental Nerve Stimulation as a Treatment for Urge Incontinence in Patients with Detrusor Instability: Results of Chronic Electrical Stimulation using an Implantable Neural ProsthesisJournal of Urology, 1995
- The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled studyBJOG: An International Journal of Obstetrics & Gynaecology, 1990